Enterome vs Orthogon Therapeutics
Enterome vs Orthogon Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and Orthogon Therapeutics on 49/100.
Where each one leads
Enterome
- our overall score: 60/100 against 49/100
- domain rating: 46/100 against 6/100
- headcount: 33 against 3
- funding raised: $124M against $34.6M
- LinkedIn following: 16,846 against 1,121
Orthogon Therapeutics
- agent readiness: 50/100 against 21/100
At a glance
| Measure | Enterome | Orthogon Therapeutics |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. | Developing first-in-class oral therapy for BK polyomavirus infections. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Services |
| Founded | 2012 | 2012 |
| Headquarters | Paris, France | Canton, USA |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Enterome | Orthogon Therapeutics |
|---|---|---|
| Employees | 33 | 3 |
| Total funding | $124M | $34.6M |
| Latest round | Later Stage VC | Follow-on |
| LinkedIn followers | 16,846 | 1,121 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Enterome | Orthogon Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 49/100 |
| Traction | 55/100 | 44/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 34/100 | 33/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 6/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Enterome | Orthogon Therapeutics |
|---|---|---|
| Hosting | Self Managed | Google Cloud |
| CMS | WordPress | Not detected |
| Frameworks | Bootstrap | Not detected |
| Analytics | Google Analytics 4, Segment | Not detected |
Enterome vs Orthogon Therapeutics: common questions
Which is better, Enterome or Orthogon Therapeutics?
On our 0-100 score Enterome rates higher (60/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Enterome and Orthogon Therapeutics compare on the numbers?
Enterome leads on our overall score (60/100 against 49/100), domain rating (46/100 against 6/100), headcount (33 against 3), funding raised ($124M against $34.6M), LinkedIn following (16,846 against 1,121). Orthogon Therapeutics leads on agent readiness (50/100 against 21/100).
Read the full Enterome review and pricing or the Orthogon Therapeutics review and pricing. You can also browse other Enterome alternatives we track.